![Magali Taiel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Magali Taiel
Director Técnico/Científico/I+D en GENSIGHT BIOLOGICS S.A. .
Perfil
Dr. Magali Taiel, MD, is a Chief Medical Officer at Gensight Biologics SA. Dr. Taiel was previously employed as a Vice President-Clinical Development by ProQR Therapeutics NV and a Project Manager by Servier SAS.
She received her doctorate degree from Universite Paris Cite.
Cargos activos de Magali Taiel
Empresas | Cargo | Inicio |
---|---|---|
GENSIGHT BIOLOGICS S.A. | Director Técnico/Científico/I+D | 08/10/2019 |
Antiguos cargos conocidos de Magali Taiel.
Empresas | Cargo | Fin |
---|---|---|
PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 01/09/2018 |
Servier SAS
![]() Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954. | Corporate Officer/Principal | 01/01/2001 |
Formación de Magali Taiel.
Universite Paris Cite | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
GENSIGHT BIOLOGICS S.A. | Health Technology |
PROQR THERAPEUTICS N.V. | Health Technology |
Empresas privadas | 1 |
---|---|
Servier SAS
![]() Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954. | Commercial Services |
- Bolsa de valores
- Insiders
- Magali Taiel